4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-21-000091
Director sold 1,666 shares at an average $53.40 ($88,969)
From the SEC's structured data for this filing
Trades in this filing
SATO VICKI L · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-15 | Sale : show line 1 in the form | −230 | $52.28 | $12,024 | 130,935 | D |
| 2021-09-15 | Sale : show line 2 in the form | −676 | $53.03 | $35,848 | 130,259 | D |
| 2021-09-15 | Sale : show line 3 in the form | −620 | $53.92 | $33,430 | 129,639 | D |
| 2021-09-15 | Sale : show line 4 in the form | −140 | $54.76 | $7,666 | 129,499 | D |
| Open-market sales · 1,666 sh · avg $53.40 · $88,969 | ||||||
Loading xslF345X03/wf-form4_163190905888608.xml…